by divibasicbldev | Jan 26, 2022 | Press Releases
In-person clinic will provide ketamine therapy and other novel mental health treatments, including repeated transcranial magnetic stimulation (“rTMS”)MIAMI BEACH, Fla., Jan. 26, 2022 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA)...
by divibasicbldev | Dec 21, 2021 | Press Releases
— Expanding Pasithea Clinics footprint in London –MIAMI BEACH, Fla., Dec. 21, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused on the...
by divibasicbldev | Dec 1, 2021 | Press Releases
— Pasithea Clinics commences in-home IV ketamine infusion therapy in Florida and Nevada — — Treatments conducted by board-certified medical professionals — — Expansion to additional U.S. cities in coming months — MIAMI BEACH, Fla.,...
by divibasicbldev | Nov 29, 2021 | Press Releases
MIAMI BEACH, Fla., Nov. 29, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA; KTTAW) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for...
by divibasicbldev | Nov 24, 2021 | Press Releases
MIAMI BEACH, Fla., Nov. 24, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA; KTTAW) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for...
by divibasicbldev | Nov 23, 2021 | Press Releases
Pasithea Clinics is one of only three accredited clinics in the U.K. approved to offer esketamine nasal spray (SPRAVATO®) for treatment of mental health disordersMIAMI BEACH, Fla., Nov. 23, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA)...